Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Parkinson's Disease

  Free Subscription


1 Ann Neurol
3 Mov Disord
2 Neurobiol Dis
3 Neurology
1 Neuropsychology
3 Neurosci Lett
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Neurol

  1. HEINZEL S, Aho VTE, Suenkel U, von Thaler AK, et al
    Gut microbiome signatures of risk and prodromal markers of Parkinson's disease.
    Ann Neurol. 2021 May 22. doi: 10.1002/ana.26128.
    PubMed         Abstract available

    Mov Disord

  2. FEARON C, Mikulis DJ, Lang AE
    Parkinsonism as a Sequela of SARS-CoV-2 Infection: Pure Hypoxic Injury or Additional COVID-19-Related Response?
    Mov Disord. 2021 May 27. doi: 10.1002/mds.28656.

  3. ORSO B, Arnaldi D, Girtler N, Brugnolo A, et al
    Dopaminergic and Serotonergic Degeneration and Cortical [(18) F]Fluorodeoxyglucose Positron Emission Tomography in De Novo Parkinson's Disease.
    Mov Disord. 2021 May 22. doi: 10.1002/mds.28654.
    PubMed         Abstract available

  4. DEAN DN, Lee JC
    Linking Parkinson's Disease and Melanoma: Interplay Between alpha-Synuclein and Pmel17 Amyloid Formation.
    Mov Disord. 2021 May 22. doi: 10.1002/mds.28655.
    PubMed         Abstract available

    Neurobiol Dis

  5. FAUSER M, Ricken M, Markert F, Weis N, et al
    Subthalamic nucleus deep brain stimulation induces sustained neurorestoration in the mesolimbic dopaminergic system in a Parkinson's disease model.
    Neurobiol Dis. 2021 May 24:105404. doi: 10.1016/j.nbd.2021.105404.
    PubMed         Abstract available

  6. TOMKINS JE, Manzoni C
    Advances in protein-protein interaction network analysis for Parkinson's disease.
    Neurobiol Dis. 2021;155:105395.
    PubMed         Abstract available


  7. IRWIN D, Saint-Hilaire M
    In Vivo Detection of Underlying Synucleinopathies: Are We There Yet?
    Neurology. 2021;96:925-926.

  8. HONG Z, Tian C, Stewart T, Aro P, et al
    Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying alpha-Synuclein-Containing Extracellular Vesicles.
    Neurology. 2021;96:e2332-e2345.
    PubMed         Abstract available

  9. GANDHI AB, Onukwugha E, Albarmawi H, Johnson A, et al
    Healthcare Resource Utilization Associated With Parkinson Disease Among Medicare Beneficiaries.
    Neurology. 2021 May 27. pii: WNL.0000000000012290.
    PubMed         Abstract available


  10. BARVAS E, Mattavelli G, Zappini F, Giardina F, et al
    Cognitive phenotypes in Parkinson's disease: A latent profile analysis.
    Neuropsychology. 2021;35:451-459.
    PubMed         Abstract available

    Neurosci Lett

  11. LI N, Suo X, Zhang J, Lei D, et al
    Disrupted functional brain network topology in Parkinson's disease patients with freezing of gait.
    Neurosci Lett. 2021 May 20:135970. doi: 10.1016/j.neulet.2021.135970.
    PubMed         Abstract available

  12. TAKAHASHI K, Iwaoka K, Takahashi K, Suzuki Y, et al
    Cerebrospinal fluid levels of oxidative stress measured using diacron-reactive oxygen metabolites and biological antioxidant potential in patients with Parkinson's disease and progressive supranuclear palsy.
    Neurosci Lett. 2021 May 20:135975. doi: 10.1016/j.neulet.2021.135975.
    PubMed         Abstract available

  13. RONG Z, Shen F, Wang Y, Sun L, et al
    Phosphorylated alpha-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear paralysis.
    Neurosci Lett. 2021;756:135964.
    PubMed         Abstract available

    PLoS One

  14. MCKAY JL, Lang KC, Bong SM, Hackney ME, et al
    Abnormal center of mass feedback responses during balance: A potential biomarker of falls in Parkinson's disease.
    PLoS One. 2021;16:e0252119.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.